Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Allergy and Clinical Immunology|October 24, 2025
Human milk oligosaccharides and polyphenols: Mechanisms, effects, and applications in allergiesChantal C M den Elzen, Ariana Carvalho, Stanislawa Bazan-Socha, et al.
European Journal of Immunology|December 21, 2012
Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammationAlexander Visekruna, Josephine Ritter, Tatjana Scholz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 18, 2007
Anti-ulcer treatment during pregnancy induces food allergy in mouse mothers and a Th2-bias in their offspringIsabella Schöll, Ute Ackermann, Cevdet Ozdemir, et al.
Brain, Behavior, and Immunity|January 6, 2026
Effects of lipopolysaccharide on energy metabolism and immune cell activation in different microglia model systemsSusanne Michels, Johanna Eichberg, Fahd Alhamdan, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2011
Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbesStephanie Brand, René Teich, Tanja Dicke, et al.
Pulmonary Pharmacology & Therapeutics|December 26, 2012
Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposureRainer Fuhst, Frank Runge, Jochen Buschmann, et al.
Nutrients|July 28, 2019
Raw Cow's Milk Reduces Allergic Symptoms in a Murine Model for Food Allergy-A Potential Role For Epigenetic ModificationsSuzanne Abbring, Johanna Wolf, Veronica Ayechu-Muruzabal, et al.
The Journal of Allergy and Clinical Immunology|June 28, 2008
Animal shed Bacillus licheniformis spores possess allergy-protective as well as inflammatory propertiesKay Vogel, Nicole Blümer, Melanie Korthals, et al.
Respiratory Research|April 5, 2018
A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trialTimm Greulich, Jens M Hohlfeld, Petra Neuser, et al.
Inflammatory Bowel Diseases|May 12, 2026
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trialRaja Atreya, Tanja Kühbacher, Michael Vieth, et al.
Pageof 12